FERRI, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 10.857
EU - Europa 1.056
AS - Asia 740
SA - Sud America 8
AF - Africa 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.675
Nazione #
US - Stati Uniti d'America 10.854
IT - Italia 502
CN - Cina 405
SG - Singapore 217
FI - Finlandia 206
SE - Svezia 99
GB - Regno Unito 94
VN - Vietnam 64
DE - Germania 54
NL - Olanda 16
UA - Ucraina 16
FR - Francia 15
IE - Irlanda 14
PK - Pakistan 11
BE - Belgio 9
TW - Taiwan 8
IN - India 6
BR - Brasile 5
JP - Giappone 5
RO - Romania 5
GR - Grecia 4
HK - Hong Kong 4
KR - Corea 4
NP - Nepal 4
NZ - Nuova Zelanda 4
AT - Austria 3
CA - Canada 3
CL - Cile 3
EE - Estonia 3
EU - Europa 3
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LU - Lussemburgo 2
PH - Filippine 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IQ - Iraq 1
KZ - Kazakistan 1
MK - Macedonia 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TR - Turchia 1
Totale 12.675
Città #
Fairfield 2.136
Woodbridge 1.395
Houston 1.106
Ashburn 855
Seattle 816
Ann Arbor 801
Cambridge 738
Wilmington 707
Chandler 408
San Diego 216
Medford 191
Princeton 191
Roxbury 171
Padova 155
Des Moines 152
Singapore 133
Beijing 101
Boardman 93
Helsinki 87
Guangzhou 79
Nanjing 74
Dong Ket 63
Milan 25
Hebei 24
London 21
Shenyang 20
New York 19
Falls Church 18
Nanchang 15
Dublin 14
Kharkiv 14
Los Angeles 14
Rome 14
Ogden 13
Shanghai 13
Borås 12
Jiaxing 11
Phoenix 10
Tappahannock 9
Verona 9
Norwalk 8
Tianjin 8
Aprilia 7
Hounslow 7
Indiana 7
Jinan 7
Parma 7
Rockville 7
Sahiwal 7
Chicago 6
Chioggia 6
Acton 5
Chiswick 5
Mestrino 5
Taipei 5
Acqui Terme 4
Binasco 4
Chieti 4
Este 4
Groningen 4
Hong Kong 4
Kilburn 4
Lappeenranta 4
Larissa 4
Legnaro 4
Messina 4
Modena 4
Mountain View 4
Paris 4
Prescot 4
Boom 3
Cagliari 3
Chengdu 3
Council Bluffs 3
Florence 3
Haikou 3
Iasi 3
Kathmandu 3
Kunming 3
Lanzhou 3
Marghera 3
New Bedfont 3
Rovigo 3
Southwark 3
Taranto 3
Ansbach 2
Bologna 2
Cairo 2
Caravaggio 2
Carentino 2
Chang-hua 2
Changsha 2
Cosenza 2
Denver 2
Duncan 2
Falkenstein 2
Farra di Soligo 2
Genoa 2
Giavera del Montello 2
Goyang-si 2
Totale 11.175
Nome #
Pharmacokinetics interactions of monoclonal antibodies 142
Pharmacology of the New P2Y(12) Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties 133
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties 125
17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy 116
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation 116
AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease 114
Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits 113
Virtual screening approach for the identification of new Rac1 inhibitors 111
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients 111
Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency 109
Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 109
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 107
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 106
Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis 106
Suppressor of Cytokine Signaling-3 (SOCS-3) induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line 104
Identification of Ellagitannins in the Unripe Fruit of Rubus Chingii Hu and Evaluation of its Potential Antidiabetic Activity 103
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors 103
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals 102
Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: role of the small G protein Rac1 101
Lipid Lowering Drugs and Inflammatory Changes: an Impact on Cardiovascular Outcomes? 101
Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol 100
Liver fat accumulation is associated with circulating PCSK9 levels 100
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells 100
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting RAC1 activation 99
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidence 98
Thematic review series : the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease 98
Upregulation of Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (Lox-1) Expression in Human Endothelial Cells by Modified High Density Lipoproteins 98
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 98
Isothiazole dioxide derivative 6n inhibits vascular smooth muscle cell proliferation and protein farnesylation 98
Non-lipid-related effects of statins 97
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer's Disease 96
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake 96
Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen 96
Differential Processing of α- and β-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7) 95
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 95
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 95
Synthesis, Structural and Biological Evaluation of Bis-Heteroarylmaleimides and Bis-Heterofused Imides 91
Direct vascular effects of HMG-CoA reductase inhibitors 91
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages 89
L-Arginine prevents inflammatory and pro-calcific differentiation of interstitial aortic valve cells 89
Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression 88
Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells 87
PCSK9 Involvement in Aortic Valve Calcification 87
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 87
Disruption of ArhGAP15 results in hyperactive Rac1, affects the architecture and function of hippocampal inhibitory neurons and causes cognitive deficits 87
Ability of simvastatin to inhibit DNA synthesis in PDGF-BB-, EGF-, LPA- and ET-1- stimulated smooth muscle cells. 86
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels 86
Dipeptide nanotubes containing unnatural fluorine-substituted β(2,3)-diarylamino acid and l-Alanine as candidates for biomedical applications 86
Synthetic peptides containing a conserved sequence motif of the Id protein family modulate vascular smooth muscle cell phenotype 86
Adipose tissue related adipokines and cytokines regulate PCSK9 expression in HepG2 cells 86
Ruolo della fosfolipasi A2 secretoria e della fosfolipasi associata alle lipoproteine nel rischio cardiovascolare 86
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 85
Peptide modulators of Rac1/Tiam1 protein-protein interaction: An alternative approach for cardiovascular diseases 85
Inhibition of smooth muscle cell migration and proliferation by statins 84
Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation 84
Monofunctional PtII Complexes Based on 8-Aminoquinoline: Synthesis and Pharmacological Characterization 84
Clinical approach to the inflammatory etiology of cardiovascular diseases 84
Chemotactic effect of prorenin on human aortic smooth muscle cells : a novel function of the (pro)renin receptor 83
Lipid-modified proteins as biomarkers for cardiovascular disease: a review 83
Farnesyltransferase inhibitors : CAAX mimetics based on different biaryl scaffolds 83
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents 83
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation 82
Antiproliferative effects on human tumor cells and rat aortic smooth muscular cells of 2,3-heteroarylmaleimides and heterofused imides 82
Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide 81
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line 81
Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts 80
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 80
Drug attrition during pre-clinical and clinical development : understanding and managing drug-induced cardiotoxicity 80
Clinical evidence of statin therapy in non-dyslipidemic disorders 80
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study 80
The brown algae fucus vesiculosus and ascophyllum nodosum reduce metabolic syndrome risk factors: A clinical study 80
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis 80
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 78
New Ras CAAX mimetics: Design, synthesis, antiproliferative activity, and RAS prenylation inhibition 78
Isothiazoles. Part XV. A mild and efficient synthesis of new antiproliferative 5-sulfanylsubstituted 3-alkylaminoisothiazole 1,1-dioxides 77
Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation 77
Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases 77
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration 77
The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells 77
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement 76
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase 75
PCSK9 induces a pro-inflammatory response in macrophages 75
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 75
Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats 75
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia 75
SUPPRESSOR OF CYTOKINE SIGNALING-3 (SOCS-3) INDUCES PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) EXPRESSION IN HEPATIC HEPG2 CELL LINE 74
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 74
Antiatherosclerotic activities of mibefradil in cell culture 73
Naturally occurring PDGF receptor inhibitors with potential anti-atherosclerotic properties 73
Left main coronary wall thickness correlates with the carotid intima media thickness and may provide a new marker of cardiovascular risk 72
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain 71
Effects of polysaccharides from Inonotus obliquus and its chromium (III) complex on advanced glycation end-products formation, α-amylase, α-glucosidase activity and H2O2-induced oxidative damage in hepatic L02 cells 71
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 70
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects 70
Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9 69
Liver fat accumulation is associated with circulating PCSK9 68
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 68
Bococizumab for the treatment of hypercholesterolaemia 68
Himalayan Nettle Girardinia diversifolia as a Candidate Ingredient for Pharmaceutical and Nutraceutical Applications-Phytochemical Analysis and In Vitro Bioassays 68
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: An Appealing Scaffold for the Design of Rac1-Tiam1 Protein-Protein Interaction Inhibitors 67
Totale 8.875
Categoria #
all - tutte 49.015
article - articoli 43.053
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 85
selected - selezionate 0
volume - volumi 141
Totale 92.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.656 336 116 28 151 286 173 249 293 327 309 198 190
2020/20212.544 177 368 131 268 104 93 94 337 293 253 262 164
2021/20222.625 133 257 326 186 124 113 128 296 138 78 231 615
2022/20231.348 347 20 14 123 261 151 25 109 182 14 77 25
2023/2024888 31 90 105 85 38 38 49 63 89 41 126 133
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 12.976